Scientists have identified a peptide in mosquito saliva that significantly reduces inflammation caused by viral infections. The compound, called sialokinin, appears to modulate immune responses through specific receptor pathways, potentially opening new avenues for anti-inflammatory treatments.
Breakthrough in Mosquito Saliva Research
Researchers have discovered that a specific compound in mosquito saliva may hold the key to reducing inflammation caused by viral infections, according to a recent scientific report. The peptide, known as sialokinin, appears to significantly modulate immune responses through neurokinin receptors, potentially offering new therapeutic approaches for mosquito-borne diseases like chikungunya virus.